Inflammatory findings on species extrapolations: humans are definitely no 70-kg mice

Modern toxicology has embraced in vitro methods, and major hopes are based on the Omics technologies and systems biology approaches they bring along (Hartung and McBride in ALTEX 28(2):83–93, 2011; Hartung et al. in ALTEX 29(2):119–28, 2012). A culture of stringent validation has been developed for such approaches (Leist et al. in ALTEX 27(4):309–317, 2010; ALTEX 29(4):373–88, 2012a; Toxicol Res 1:8–22, 2012b), while the quality and usefulness of animal experiments have been little scrutinized. A new study (Seok et al. 2013) now shows the low predictivity of animal responses in the field of inflammation. These findings corroborate earlier findings from comparisons in the fields of neurodegeneration, stroke and sepsis. The low predictivity of animal experiments in research areas allowing direct comparisons of mouse versus human data puts strong doubt on the usefulness of animal data as key technology to predict human safety.

[1]  I. Cuthill,et al.  Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .

[2]  Mardas Daneshian,et al.  Critical evaluation of the use of dogs in biomedical research and testing in Europe. , 2011, ALTEX.

[3]  Gian Paolo Rossini,et al.  Towards tailored assays for cell-based approaches to toxicity testing. , 2012, ALTEX.

[4]  Thomas Hartung,et al.  The dawning of a new age of toxicology. , 2008, ALTEX.

[5]  David J Gladstone,et al.  Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions , 2002, Stroke.

[6]  R. Matthews,et al.  Medical progress depends on animal models - doesn't it? , 2008, Journal of the Royal Society of Medicine.

[7]  P. Sandercock,et al.  Comparison of treatment effects between animal experiments and clinical trials: systematic review , 2007, BMJ : British Medical Journal.

[8]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[9]  Mardas Daneshian,et al.  Validation and quality control of replacement alternatives - Current status and future challenges , 2012 .

[10]  Thomas Hartung,et al.  Food for thought... on animal tests. , 2008, ALTEX.

[11]  G. Donnan,et al.  1,026 Experimental treatments in acute stroke , 2006, Annals of neurology.

[12]  Malcolm Macleod,et al.  Animal models of neurological disease: are there any babies in the bathwater? , 2010, Practical Neurology.

[13]  M. Leist,et al.  Food for thought... on the real success of 3R approaches. , 2008, ALTEX.

[14]  R. Gamelli,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[15]  Thomas Hartung,et al.  Food for Thought ... on mapping the human toxome. , 2011, ALTEX.

[16]  D. Redelmeier,et al.  Translation of research evidence from animals to humans. , 2006, JAMA.

[17]  Susan Green,et al.  Medical progress depends on animal models – doesn't it? , 2008, Journal of the Royal Society of Medicine.

[18]  Thomas Hartung,et al.  Alternative approaches for medical countermeasures to biological and chemical terrorism and warfare. , 2012, ALTEX.

[19]  D. Howells,et al.  Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy , 2010, PLoS biology.

[20]  Dwaine F. Emerich Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? , 1999 .

[21]  Panagiota Anyfanti,et al.  Immunomodulatory therapy for sepsis: an update , 2011, Expert review of anti-infective therapy.

[22]  D. Housman,et al.  Ouabain resistance conferred by expression of the cDNA for a murine Na+, K+-ATPase alpha subunit. , 1987, Science.

[23]  Raccoon and Dog The best laid plans of mice and men , 2014, SOEN.

[24]  T. Hartung Toxicology for the twenty-first century , 2009, Nature.

[25]  A. Schnerch,et al.  Distinguishing Between Mouse and Human Pluripotent Stem Cell Regulation: The Best Laid Plans of Mice and Men , 2010, Stem cells.

[26]  D. Rittirsch,et al.  The disconnect between animal models of sepsis and human sepsis , 2007, Journal of leukocyte biology.

[27]  Thomas Vogl,et al.  Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel , 2010, Nature Immunology.

[28]  Thomas B Knudsen,et al.  Systems Toxicology , 2015, International journal of toxicology.

[29]  M. Youdim,et al.  The Future of Neuroprotection , 1999, Annals of the New York Academy of Sciences.

[30]  Marcel Leist,et al.  Food for thought ... considerations and guidelines for basic test method descriptions in toxicology. , 2010, ALTEX.

[31]  Douglas G. Altman,et al.  Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research , 2010, Journal of pharmacology & pharmacotherapeutics.

[32]  Chihae Yang,et al.  Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods. , 2012, ALTEX.

[33]  M. Macleod,et al.  Preclinical studies of human disease: time to take methodological quality seriously. , 2011, Journal of molecular and cellular cardiology.

[34]  L. Gold,et al.  Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  P. Lane,et al.  A broader view of animal research , 2007, BMJ : British Medical Journal.

[36]  Ulrich Dirnagl,et al.  International, Multicenter Randomized Preclinical Trials in Translational Stroke Research: It's Time to Act , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  D. Howells,et al.  Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.

[38]  Thomas Hartung,et al.  Food for thought ... on the evolution of toxicology and the phasing out of animal testing. , 2008, ALTEX.

[39]  Thomas Hartung,et al.  Food for thought ... on alternative methods for cosmetics safety testing. , 2008, ALTEX.

[40]  M. Wadhwa,et al.  “Cytokine Storm” in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics , 2007, The Journal of Immunology.

[41]  M. Fisher,et al.  Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials , 2007, Annals of neurology.

[42]  P. Sandercock,et al.  Comparison of treatment effects between animal experiments and clinical trials: systematic review , 2006, BMJ : British Medical Journal.

[43]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .

[44]  Amy Ellis,et al.  Critical evaluation of the use of dogs in biomedical research and testing , 2011 .

[45]  M. Sitkovsky,et al.  Model organisms: Animal Models of sepsis: setting the stage , 2005, Nature Reviews Drug Discovery.

[46]  Bas J Blaauboer,et al.  The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. , 2012, ALTEX.

[47]  Mardas Daneshian,et al.  Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test. , 2013, ALTEX.

[48]  A. Pérez-Bouza,et al.  Neurally Mediated Airway Constriction in Human and Other Species: A Comparative Study Using Precision-Cut Lung Slices (PCLS) , 2012, PloS one.

[49]  J. Keyser,et al.  Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? , 1999, Trends in Neurosciences.

[50]  S. Opal,et al.  Clinical trials for severe sepsis. Past failures, and future hopes. , 1999, Infectious disease clinics of North America.

[51]  U. Dirnagl,et al.  REPRINT: International, multicenter randomized preclinical trials in translational stroke research: it is time to act. , 2012, Stroke.

[52]  T. Knudsen,et al.  A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing. , 2012, ALTEX.

[53]  D. Blacker Food for thought. , 2013, JAMA neurology.